Beginning 1/1/2027, requires health insurers, mutual benefit societies, and health maintenance organizations that issue policies, contracts, plans, or agreements that provide prescription drug coverage to provide coverage for at least one generic opioid antagonist and device.
- Chamber
- House
- Introduced
- Jan 21, 2026
- Last action
- Jan 21, 2026 — Pending introduction.
- Session
- 2026
- Momentum
- 45 · Moderate